assessment atherosclerosis role flow-mediated dilatation pubmed ncbi abstract evidence suggests endothelial dysfunction causal pathway atherogenesis destabilization established plaques review role flow-mediated dilatation fmd non-invasive method assess endothelial function discussed technical modifications development analysis software significantly improved variability method strict standardized protocol enables reproducible measurements achieved export technique specialized laboratories population studies multicentre settings endothelial function assessed fmd shown affected cardiovascular risk factors related structural arterial disease cardiovascular outcome validating studying pathophysiology arterial disease numerous studies demonstrated responsive physiological pharmacological interventions flow-mediated dilatation unique opportunities drug development programmes assess early rapidly responsive signal risk benefit complementing endpoints structural arterial disease cardiovascular outcomes longer expensive 
